erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
RSL3 - Stanford University
Recent progress of ferroptosis in cancers and drug discovery. (PubMed, Asian J Pharm Sci) - Sep 9, 2024 - "In addition, a series of small-molecule compounds have been developed, including erastin, RSL3, and FIN56, which can be used as ferroptosis inducers. Therefore, a thorough understanding of the roles of ferroptosis in cancer is of great significance for the treatment of cancer. This review mainly elaborates the molecular biological characteristics and mechanism of ferroptosis, summarizes the function of ferroptosis in cancer development and treatment,illustrates the application of ferroptosis in patient's prognosis prediction and drug discovery, and discusses the prospects of targeting ferroptosis." 
Journal • Review • Oncology
http://www.ncbi.nlm.nih.gov/pubmed/39246507
 
Binxin Chen; Guoqing Ru; Jun Deng; Nengming Lin; Qi Li; Xiang Wang; Xinxin Ren; Xu Lin; Ying Luo; Yingqiong Zhang
 
Sep 9, 2024
 
Prev Next